Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion.

J Hepatocell Carcinoma · 2020 · PMC7762763 · PMID 33376711

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Of note, lenvatinib was associated with the greatest relative efficacy compared with sorafenib in patients with HBV, but the difference did not reach statistical significance. 16 The data regarding efficacy according to viral etiology are based on post hoc analyses.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.